New therapies for relapsed or refractory aggressive B‐cell lymphoma increase survival: Analysis from the RELINF registry of the GELTAMO group - Mariana Bastos‐Oreiro; Pau Abrisqueta; Antonio Gutierrez; Ana Jiménez Ubieto; Maria Poza; Paula Fernanez‐Caldas; María José LLacer; Sonia Gonzalez de Villambrosia; Raúl Córdoba; Alberto López; Elena Ceballos; Belen Navarro; et al. (HemaSphere, 2024)